StreetAlpha
13F holdings · Q3 2026

SR One Capital Management

Redwood City, CA · files as SR One Capital Management, LP
Know the moment SR One Capital Management filesYou follow SR One Capital Management An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 1910264

SR One Capital Management reported 17 stocks worth $1.1B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are MANE (21.9%), ADRX (17.2%) and ZBIO (11.8%). Compared with Q2 2026, the fund opened new positions in ADRX, KRSA and ENGN and trimmed MANE.

Latest filing: what SR One Capital Management did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
3 new0 added1 trimmed1 sold outBought about $219M · sold about $40.3M
New 3
Added 0

None

Trimmed 1
Sold out 1
  • Engene Holdings In$1.3M

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$1.1B+10.6% vs last quarter
Stocks held173 new · 1 sold out
Top 5 weight69.0%very concentrated
Turnover23%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
MANE
Veradermics Inc
$252M21.9%2.1M−322K (−13%)3 of 8
2
ADRX
Adarx Pharmaceuticals Inc
$198M17.2%9.9MNew position1 of 8
3
ZBIO
Zenas Biopharma Inc
$136M11.8%5MNo change8 of 8
4
CRSP
Crispr Therapeutics
$113M9.8%2MNo change8 of 8
5
AVLN
Avalyn Pharma Inc
$94.3M8.2%3.3MNo change2 of 8
6
ODTX
Odyssey Therapeutics, Inc.
$84.3M7.3%3.8MNo change2 of 8
7
DSGN
Design Therapeutics Inc
$82M7.1%6.5MNo change8 of 8
8
ORIC
Oric Pharmaceuticals Inc
$62.2M5.4%4.6MNo change6 of 8
9
MLYS
Mineralys Therapeutics Inc
$39.3M3.4%1.6MNo change8 of 8
10
KRSA
Korsana Biosciences Inc
$19.6M1.7%614KNew position1 of 8
🔒 7 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
ENGENE HOLDINGS INC
$1.3M748K

Reported value

last 8 quarters
$410MQ4 '24
$389MQ1 '25
$461MQ2 '25
$691MQ3 '25
$706MQ4 '25
$915MQ1 '26
$1BQ2 '26
$1.1BQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

SR One Capital Management 13F FAQ

What does SR One Capital Management own?

SR One Capital Management reported 17 stocks worth $1.1B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are MANE (21.9%), ADRX (17.2%) and ZBIO (11.8%). The table above lists every position in the filing (the top 10 without an account).

What did SR One Capital Management buy and sell in Q3 2026?

Compared with Q2 2026: 3 new positions, 0 added to, 1 trimmed and 1 sold out. New positions include ADRX, KRSA and ENGN.

When will SR One Capital Management file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is SR One Capital Management's portfolio worth?

The Q3 2026 filing reports $1.1B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.